Haya R Rubin, MD
Internal Medicine · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
- Since medical school
- 44 years
- Graduated 1982
On the public record
- California licence: Delinquent
Offices
5 locations · Lakewood Medical Associates · 3 clinicians in this group
Hospitals listed: Monmouth Medical Center-Southern Campus. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Rubin’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G59862 · Delinquent
Licence status: Delinquent · since 1987 · expires 2025-03-31 · University of Southern California Keck School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- New Jersey 25MA11063400Medical Doctor · since 2021 · expires 2027-06-30Matched by name, not licence number; check the name before relying on it.ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 49.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Monmouth Medical Center-Southern CampusLakewood, NJAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of RWJBarnabas Health, which runs 16 hospitalsPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.287, Oct 2024 – Sep 2025
See every measure and the patient survey for Monmouth Medical Center-Southern Campus
Behind the star rating — Deaths: 1 better, 5 the same, 0 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.287 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.21 to 2.33) · 359 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1 (0.59 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 49 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.2 · 210 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.8 · 492 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.9 · 69 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,167 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,591 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,589 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.64 to 5.66) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.24 (0.54 to 3.94) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.27) · 47 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.77 (0 to 1.58) · 3,059 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.427 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.518 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 269 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 31.4 · 246 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 42.7 · 500 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 494 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.4 to 8) · 62 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 15 (10.7 to 20.3) · 62 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.9 · 121 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.7 to 18.1) · 73 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 108 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 60% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$29,898
Medicare paid this office $29,898 for 68 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 24 | $9,690 | $133 |
| Long return visit (40+ min) | 23 | $5,178 | $136 |
| Telephone medical discussion with physician, 21-30 minutes | 30 | $4,215 | $81 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19 | $2,657 | $140 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 13 | $2,431 | $106 |
See all 8 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 24 | $9,690 | $133 |
| Long return visit (40+ min) | 23 | $5,178 | $136 |
| Telephone medical discussion with physician, 21-30 minutes | 30 | $4,215 | $81 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19 | $2,657 | $140 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 13 | $2,431 | $106 |
| Return visit (30+ min) | 11 | $1,212 | $87 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $811 | $54 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 16 | $230 | $13 |
Who their Medicare patients are
68 Original Medicare patients in 2024. Average age 81 · Under 65 0% · 85 and older 29% · Women 74% · Health risk score 1.93. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Atrial fibrillation 35% · Diabetes 34% · Coronary heart disease 29% · Heart failure 26% · Dementia 26% · Chronic kidney disease 21% · Depression 18% · Stroke 16%.
The office billed $88,003, Medicare allowed $40,716 and paid $29,898; for 312 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 68 | 312 | 81 | 1.93 | $88,003 | $29,898 |
| 2023 | 62 | 323 | 79 | 2.42 | $99,080 | $34,307 |
| 2022 | 74 | 318 | 78 | 1.61 | $87,222 | $34,034 |
| 2021 | 52 | 191 | 79 | 1.45 | $43,473 | $20,003 |
| 2020 | 14 | 89 | 86 | 1.30 | $20,772 | $9,767 |
| 2019 | 11 | 48 | 85 | 1.36 | $16,760 | $6,405 |
| 2018 | 16 | 92 | 87 | 1.51 | $26,036 | $12,276 |
| 2017 | 126 | 447 | 76 | 1.10 | $127,886 | $45,952 |
| 2016 | 63 | 273 | 80 | 1.57 | $80,285 | $30,355 |
| 2015 | 81 | 206 | 81 | 1.23 | $28,679 | $18,242 |
| 2014 | 121 | 598 | 80 | 1.05 | $76,654 | $57,216 |
| 2013 | 138 | 631 | 79 | 1.10 | $77,131 | $56,388 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 25 | $12,937 | $150 |
| Long return visit (40+ min) | 25 | $6,169 | $134 |
| Telephone medical discussion with physician, 21-30 minutes | 34 | $4,721 | $79 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,062 | $137 |
| Return visit (30+ min) | 13 | $1,816 | $107 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $1,219 | $53 |
| Administration of influenza virus vaccine | 12 | $394 | $33 |
2022: 6 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 22 | $11,401 | $148 |
| Long return visit (40+ min) | 24 | $6,155 | $150 |
| Telephone medical discussion with physician, 21-30 minutes | 32 | $4,125 | $92 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 20 | $2,827 | $141 |
| Return visit (30+ min) | 19 | $2,679 | $107 |
| Telephone medical discussion with physician, 11-20 minutes | 26 | $2,047 | $64 |
2021: 4 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 18 | $5,667 | $149 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $3,599 | $120 |
| Long return visit (40+ min) | 11 | $1,778 | $162 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $975 | $49 |
2018: 1 service
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 16 | $9,116 | $152 |
2017: 9 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 17 | $9,534 | $149 |
| New patient visit (60+ min) | 57 | $9,112 | $160 |
| Long return visit (40+ min) | 42 | $7,141 | $112 |
| Return visit (30+ min) | 42 | $5,459 | $84 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 30 | $3,420 | $114 |
| New patient visit (30+ min) | 27 | $2,269 | $84 |
| Short return visit (20+ min) | 31 | $2,171 | $57 |
| New patient visit (45+ min) | 12 | $1,527 | $127 |
| Annual depression screening, 5 to 15 minutes | 19 | $340 | $18 |
2016: 5 services
| Long return visit (40+ min) | 48 | $13,809 | $128 |
| Extended office or other outpatient service, first hour | 28 | $3,986 | $89 |
| Return visit (30+ min) | 26 | $3,160 | $88 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 12 | $2,237 | $97 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,889 | $135 |
2015: 3 services
| Return visit (30+ min) | 60 | $7,588 | $81 |
| Long return visit (40+ min) | 26 | $3,757 | $121 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 14 | $2,397 | $89 |
2014: 8 services
| Long return visit (40+ min) | 73 | $20,893 | $125 |
| Return visit (30+ min) | 92 | $18,824 | $93 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 38 | $5,050 | $133 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 17 | $2,783 | $87 |
| Short return visit (20+ min) | 36 | $2,675 | $61 |
| Extended office or other outpatient service, first hour | 12 | $1,050 | $88 |
| Administration of influenza virus vaccine | 12 | $337 | $28 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 12 | $142 | $12 |
2013: 5 services
| Return visit (30+ min) | 112 | $23,227 | $90 |
| Long return visit (40+ min) | 53 | $7,752 | $116 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 22 | $7,305 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 39 | $5,204 | $133 |
| Short return visit (20+ min) | 55 | $4,675 | $58 |
Drugs they prescribed that Part D paid
$77,999
Pharmacies billed $77,999 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 772) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
675 generic and 97 brand-name prescriptions · $77,999 in drug cost · 79 antibiotic prescriptions to 31 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 32 | $32,271 | $1,008 |
| Januvia | 16 | $11,387 | $712 |
| Methenamine Hippurate | 25 | $2,514 | $101 |
| Levothyroxine | 61 | $992 | $16 |
| Atorvastatin | 32 | $535 | $17 |
See all 18 drugs
| Eliquis | 32 | $32,271 | $1,008 |
| Januvia | 16 | $11,387 | $712 |
| Methenamine Hippurate | 25 | $2,514 | $101 |
| Levothyroxine | 61 | $992 | $16 |
| Atorvastatin | 32 | $535 | $17 |
| Escitalopram | 17 | $515 | $30 |
| Metformin | 34 | $512 | $15 |
| Gabapentin | 29 | $487 | $17 |
| Digoxin | 11 | $358 | $33 |
| Buspirone | 14 | $316 | $23 |
| Sertraline | 22 | $297 | $14 |
| Cephalexin | 32 | $260 | $8 |
| Methylphenidate | 12 | $185 | $15 |
| Furosemide | 14 | $169 | $12 |
| Metoprolol | 12 | $140 | $12 |
| Pravastatin | 30 | $138 | $5 |
| Amlodipine Besylate | 11 | $78 | $7 |
| Alendronate | 14 | $55 | $4 |
Year by year
| 2024 | 772 | 69 | 0% (0) | 13% | $77,999 |
| 2023 | 654 | 68 | None | None | $84,861 |
| 2022 | 456 | 65 | 3% (13) | 14% | $50,738 |
| 2021 | 494 | 51 | None | None | $36,511 |
| 2020 | 1,586 | 97 | None | 33% | $122,635 |
| 2019 | 378 | 80 | None | None | $39,777 |
| 2018 | 487 | 117 | 0% (0) | None | $59,554 |
| 2017 | 627 | 108 | 0% (0) | None | $53,824 |
| 2016 | 767 | 91 | None | 18% | $73,865 |
| 2015 | 959 | 93 | None | 25% | $92,466 |
| 2014 | 1,120 | 98 | None | 25% | $109,859 |
| 2013 | 1,265 | 94 | None | 28% | $107,161 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Eliquis | 18 | $23,725 | $1,318 |
| Januvia | 11 | $6,628 | $603 |
| Methenamine Hippurate | 16 | $2,310 | $144 |
| Levothyroxine | 69 | $1,392 | $20 |
| Sertraline | 11 | $923 | $84 |
| Nystatin | 13 | $595 | $46 |
| Pravastatin | 30 | $467 | $16 |
| Gabapentin | 22 | $371 | $17 |
| Cephalexin | 20 | $368 | $18 |
| Escitalopram | 13 | $356 | $27 |
| Alendronate | 13 | $218 | $17 |
| Trazodone | 11 | $206 | $19 |
| Azithromycin | 18 | $198 | $11 |
| Atorvastatin | 21 | $172 | $8 |
| Metformin | 15 | $111 | $7 |
2022: 14 drugs
| Eliquis | 17 | $16,334 | $961 |
| Sertraline | 13 | $1,551 | $119 |
| Nystatin | 27 | $1,080 | $40 |
| Levothyroxine | 37 | $872 | $24 |
| Levetiracetam | 14 | $849 | $61 |
| Pravastatin | 23 | $433 | $19 |
| Gabapentin | 13 | $294 | $23 |
| Cephalexin | 25 | $280 | $11 |
| Amlodipine Besylate | 18 | $234 | $13 |
| Paxlovid (Eua) | 13 | $140 | $11 |
| Levofloxacin | 11 | $137 | $12 |
| Chlorhexidine Gluconate | 14 | $111 | $8 |
| Atorvastatin | 11 | $103 | $9 |
| Furosemide | 11 | $93 | $8 |
2021: 12 drugs
| Nuedexta | 24 | $15,856 | $661 |
| Mirtazapine | 19 | $822 | $43 |
| Levothyroxine | 76 | $714 | $9 |
| Alendronate | 19 | $606 | $32 |
| Pravastatin | 13 | $417 | $32 |
| Atorvastatin | 17 | $312 | $18 |
| Gabapentin | 18 | $307 | $17 |
| Amlodipine Besylate | 21 | $157 | $7 |
| Famotidine | 14 | $154 | $11 |
| Tamsulosin | 12 | $146 | $12 |
| Metoprolol | 14 | $132 | $9 |
| Furosemide | 12 | $129 | $11 |
2020: 41 drugs
| Nuedexta | 69 | $42,828 | $621 |
| Eliquis | 43 | $10,067 | $234 |
| Xarelto | 40 | $9,754 | $244 |
| Myrbetriq | 19 | $3,789 | $199 |
| Budesonide | 14 | $2,383 | $170 |
| Levothyroxine | 180 | $1,675 | $9 |
| Memantine | 39 | $1,587 | $41 |
| Fluoxetine | 15 | $1,451 | $97 |
| Amiodarone | 19 | $1,447 | $76 |
| Atorvastatin | 62 | $1,165 | $19 |
| Divalproex | 21 | $1,128 | $54 |
| Donepezil | 15 | $1,048 | $70 |
| Mirtazapine | 34 | $932 | $27 |
| Levetiracetam | 16 | $844 | $53 |
| Pravastatin | 31 | $794 | $26 |
| Gabapentin | 32 | $761 | $24 |
| Amlodipine Besylate | 43 | $656 | $15 |
| Ondansetron | 20 | $573 | $29 |
| Nystop | 17 | $556 | $33 |
| Famotidine | 35 | $439 | $13 |
| Carbidopa-Levodopa | 13 | $427 | $33 |
| Escitalopram | 28 | $413 | $15 |
| Alendronate | 21 | $371 | $18 |
| Metoprolol | 39 | $361 | $9 |
| Furosemide | 59 | $339 | $6 |
| Omeprazole | 23 | $335 | $15 |
| Losartan | 19 | $335 | $18 |
| Metoprolol | 22 | $312 | $14 |
| Clopidogrel | 19 | $292 | $15 |
| Quetiapine | 22 | $290 | $13 |
| Potassium Chloride | 21 | $284 | $14 |
| Hydrochlorothiazide | 26 | $267 | $10 |
| Tamsulosin | 16 | $264 | $17 |
| Ipratropium-Albuterol | 16 | $221 | $14 |
| Carvedilol | 17 | $169 | $10 |
| Citalopram Hbr | 15 | $144 | $10 |
| Lisinopril | 17 | $136 | $8 |
| Warfarin | 12 | $125 | $10 |
| Hydralazine | 12 | $125 | $10 |
| Metformin | 15 | $108 | $7 |
| Allopurinol | 13 | $102 | $8 |
2019: 10 drugs
| Eliquis | 15 | $2,575 | $172 |
| Pravastatin | 21 | $522 | $25 |
| Clopidogrel | 17 | $353 | $21 |
| Atorvastatin | 13 | $329 | $25 |
| Metoprolol | 17 | $272 | $16 |
| Alendronate | 11 | $242 | $22 |
| Levothyroxine | 14 | $242 | $17 |
| Carvedilol | 11 | $207 | $19 |
| Furosemide | 22 | $135 | $6 |
| Lisinopril | 14 | $130 | $9 |
2018: 11 drugs
| Pravastatin | 21 | $751 | $36 |
| Metoprolol | 14 | $524 | $37 |
| Atorvastatin | 14 | $440 | $31 |
| Fluoxetine | 12 | $291 | $24 |
| Losartan | 19 | $189 | $10 |
| Metformin | 12 | $134 | $11 |
| Hydrochlorothiazide | 11 | $131 | $12 |
| Furosemide | 16 | $91 | $6 |
| Amlodipine Besylate | 12 | $82 | $7 |
| Lisinopril | 12 | $54 | $4 |
| Omeprazole | 11 | $40 | $4 |
2017: 12 drugs
| Crestor | 11 | $4,299 | $391 |
| Metoprolol | 39 | $917 | $24 |
| Levothyroxine | 27 | $675 | $25 |
| Pravastatin | 19 | $495 | $26 |
| Losartan | 31 | $407 | $13 |
| Hydrochlorothiazide | 15 | $196 | $13 |
| Lisinopril | 17 | $170 | $10 |
| Polyethylene Glycol 3350 | 18 | $169 | $9 |
| Metformin | 15 | $146 | $10 |
| Alendronate | 11 | $138 | $13 |
| Amlodipine Besylate | 14 | $122 | $9 |
| Carvedilol | 11 | $67 | $6 |
2016: 18 drugs
| Raloxifene | 16 | $2,361 | $148 |
| Levothyroxine | 51 | $1,226 | $24 |
| Pravastatin | 22 | $660 | $30 |
| Duloxetine | 11 | $620 | $56 |
| Metoprolol | 20 | $619 | $31 |
| Losartan | 48 | $572 | $12 |
| Amlodipine Besylate | 40 | $426 | $11 |
| Zolpidem | 12 | $395 | $33 |
| Montelukast | 11 | $378 | $34 |
| Alendronate | 14 | $265 | $19 |
| Allopurinol | 17 | $265 | $16 |
| Metformin | 23 | $226 | $10 |
| Hydrochlorothiazide | 13 | $180 | $14 |
| Lisinopril | 21 | $176 | $8 |
| Glimepiride | 15 | $160 | $11 |
| Atenolol | 15 | $158 | $11 |
| Polyethylene Glycol 3350 | 12 | $145 | $12 |
| Buspirone | 22 | $111 | $5 |
2015: 25 drugs
| Welchol | 15 | $11,484 | $766 |
| Byetta | 13 | $6,558 | $504 |
| Dexilant | 18 | $4,312 | $240 |
| Raloxifene | 16 | $4,107 | $257 |
| Levothyroxine | 51 | $1,453 | $28 |
| Pravastatin | 34 | $1,235 | $36 |
| Estradiol | 16 | $918 | $57 |
| Metoprolol | 21 | $880 | $42 |
| Losartan | 58 | $691 | $12 |
| Metformin | 43 | $413 | $10 |
| Amlodipine Besylate | 46 | $391 | $9 |
| Zolpidem | 17 | $321 | $19 |
| Alendronate | 15 | $261 | $17 |
| Hydrochlorothiazide | 17 | $257 | $15 |
| Spironolactone | 19 | $248 | $13 |
| Amitriptyline | 14 | $236 | $17 |
| Allopurinol | 15 | $209 | $14 |
| Lisinopril | 26 | $202 | $8 |
| Polyethylene Glycol 3350 | 13 | $180 | $14 |
| Gabapentin | 18 | $159 | $9 |
| Sertraline | 12 | $153 | $13 |
| Simvastatin | 22 | $150 | $7 |
| Atenolol | 19 | $149 | $8 |
| Triamterene-Hydrochlorothiazid | 11 | $132 | $12 |
| Furosemide | 12 | $123 | $10 |
2014: 35 drugs
| Januvia | 17 | $7,823 | $460 |
| Welchol | 11 | $7,241 | $658 |
| Crestor | 14 | $6,956 | $497 |
| Byetta | 11 | $4,642 | $422 |
| Celebrex | 15 | $4,548 | $303 |
| Donepezil | 14 | $3,355 | $240 |
| Duloxetine | 12 | $1,797 | $150 |
| Pravastatin | 45 | $1,736 | $39 |
| Metoprolol | 24 | $1,653 | $69 |
| Levothyroxine | 55 | $1,432 | $26 |
| Norvasc | 12 | $1,235 | $103 |
| Losartan | 55 | $724 | $13 |
| Valsartan-Hydrochlorothiazide | 15 | $716 | $48 |
| Metformin | 66 | $683 | $10 |
| Synthroid | 13 | $464 | $36 |
| Amlodipine Besylate | 33 | $442 | $13 |
| Hydrochlorothiazide | 26 | $418 | $16 |
| Simvastatin | 28 | $390 | $14 |
| Alendronate | 18 | $328 | $18 |
| Lisinopril | 24 | $319 | $13 |
| Atorvastatin | 13 | $305 | $23 |
| Atenolol | 19 | $260 | $14 |
| Warfarin | 12 | $204 | $17 |
| Losartan-Hydrochlorothiazide | 11 | $202 | $18 |
| Lovastatin | 15 | $195 | $13 |
| Triamterene-Hydrochlorothiazid | 15 | $181 | $12 |
| Allopurinol | 15 | $176 | $12 |
| Polyethylene Glycol 3350 | 12 | $164 | $14 |
| Clopidogrel | 16 | $161 | $10 |
| Gabapentin | 11 | $156 | $14 |
| Sertraline | 11 | $151 | $14 |
| Zolpidem | 20 | $113 | $6 |
| Omeprazole | 12 | $109 | $9 |
| Furosemide | 18 | $88 | $5 |
| Folic Acid | 12 | $22 | $2 |
2013: 38 drugs
| Janumet | 16 | $6,483 | $405 |
| Januvia | 22 | $6,289 | $286 |
| Crestor | 13 | $5,788 | $445 |
| Evista | 11 | $5,573 | $507 |
| Byetta | 13 | $4,646 | $357 |
| Namenda | 12 | $3,769 | $314 |
| Cymbalta | 12 | $2,996 | $250 |
| Valsartan-Hydrochlorothiazide | 21 | $2,937 | $140 |
| Diovan | 13 | $2,928 | $225 |
| Celebrex | 11 | $1,917 | $174 |
| Metoprolol | 37 | $1,886 | $51 |
| Lantus | 11 | $1,662 | $151 |
| Atorvastatin | 39 | $1,449 | $37 |
| Losartan | 50 | $1,352 | $27 |
| Voltaren | 15 | $1,291 | $86 |
| Donepezil | 21 | $1,270 | $60 |
| Pravastatin | 48 | $1,054 | $22 |
| Levothyroxine | 73 | $1,035 | $14 |
| Metformin | 50 | $831 | $17 |
| Bupropion Xl | 11 | $576 | $52 |
| Alendronate | 27 | $524 | $19 |
| Clopidogrel | 26 | $521 | $20 |
| Simvastatin | 28 | $511 | $18 |
| Amlodipine Besylate | 32 | $501 | $16 |
| Oxybutynin Chloride Er | 12 | $481 | $40 |
| Warfarin | 19 | $418 | $22 |
| Lisinopril | 36 | $346 | $10 |
| Synthroid | 16 | $321 | $20 |
| Atenolol | 33 | $291 | $9 |
| Polyethylene Glycol 3350 | 15 | $289 | $19 |
| Triamterene-Hctz | 22 | $241 | $11 |
| Glyburide | 12 | $233 | $19 |
| Sertraline | 16 | $212 | $13 |
| Zolpidem | 24 | $169 | $7 |
| Allopurinol | 15 | $157 | $10 |
| Benazepril | 11 | $148 | $13 |
| Hydrochlorothiazide | 16 | $133 | $8 |
| Folic Acid | 12 | $23 | $2 |
Money from drug and device companies
$18 in 2025
A payment is not proof that care is biased.
| Lilly USA | Kisunla | $18 | 1 payment
|
See the published payment
| Lilly USA | Meals · 2025-08-27 | Kisunla | $18 |
Professional record
- NPI
- 1619058864
- Licence
- CA G59862California G59862: Delinquent · expires 2025-03-31New Jersey 25MA11063400: Active
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 2290 W County Line Rd Ste 101, Jackson, NJ, 08527
- NPI first listed
- 2006-10-17
- NPI last updated
- 2022-04-21
- NPI record certified
- 2022-04-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2290 W County Line Rd Ste 101, Jackson, NJ, 08527